WAI CHUN BIOTEC(00660): Possible delay in publishing full-year performance.
Weijun Biotechnology (00660) issued an announcement that the company's Chief Financial Officer will be on leave from September 14, 2024 due to family reasons.
WAI CHUN BIOTEC (00660) announces that the company's Chief Financial Officer has resigned from September 14, 2024 due to personal reasons, causing hindrances in providing information and documents to the auditors. As a result, the company needs additional time to finalize the audited financial results for the year ending June 30, 2024, and it may be delayed beyond the original announcement date of September 30, 2024.
The company is working closely with the auditors to provide all required information and documents to expedite the auditing process. However, the expected announcement date for the annual results will need to be further determined with the auditors and will be announced separately.
Related Articles

Market sounds the alarm! The liquidity engine has stalled, and macroeconomic data is starting to weaken.

C HEALTH GP(08225) officially launches multiple AI-RWS research projects, leading the new track of "AI+ clinical research".

The comprehensive net asset value per share of WALNUT CAP (00905) at the end of August is approximately HK$0.289.
Market sounds the alarm! The liquidity engine has stalled, and macroeconomic data is starting to weaken.

C HEALTH GP(08225) officially launches multiple AI-RWS research projects, leading the new track of "AI+ clinical research".

The comprehensive net asset value per share of WALNUT CAP (00905) at the end of August is approximately HK$0.289.

RECOMMEND

Hong Kong Stock Concept Tracker|Oracle (ORCL.US) RPO Surge Ignites AI Computing Power Chain—Domestic Opportunities in Focus
11/09/2025

Southbound Capital Flows Shift: Profit-Taking on High-Flying Stocks and Accumulating Alibaba and Tence
11/09/2025

Anti-Involution Policies Deliver Results as August Price Indicators Improve
11/09/2025